Lexpos News

Community Pharmacy England has launched its fifth annual Pharmacy Pressures Survey, and we are keen to hear from all pharmacy owners and staff. The survey is crucial for monitoring the health of the sector. Its findings provide clear evidence of the realities facing community pharmacy. We know that being asked for feedback every year can [...]

The post Pharmacy Pressures Survey 2026: Your responses help secure our future appeared first on Community Pharmacy England.

Community Pharmacy England is aware of a recent increase in scam emails being sent to community pharmacies. Some of these messages falsely claim that the pharmacy is under investigation for a data protection or GDPR compliance breach. These emails can appear convincing at first glance. However, they often feature significant warning signs and should be [...]

The post Pharmacies urged to be alert to GDPR themed scam emails appeared first on Community Pharmacy England.

Following the completion of a safety review and the recommendations of the Commission on Human Medicines (CHM), the IXCHIQ Chikungunya vaccine is no longer indicated for adults over the age of 60 years, and is contraindicated in all individuals with hypertension, cardiovascular disease, diabetes mellitus, and/or chronic kidney disease. This action follows very rare fatal [...]

The post MHRA Drug Safety Update: IXCHIQ Chikungunya vaccine – updates to restrictions of use following safety review appeared first on Community Pharmacy England.

Pharmacy teams should be aware that FreeStyle® Libre 3 Sensor (Abbott Laboratories Ltd) has been discontinued and will be deleted from Part IX of the April 2026  Drug Tariff. Any NHS prescriptions for the FreeStyle® Libre 3 Sensor dispensed from 1 April 2026 will be disallowed by the NHS Business Services Authority (NHSBSA). Patients currently using the [...]

The post Discontinuation of FreeStyle® Libre 3 Sensor appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfadiazine silver (Flamazine®) 1% cream. MSN/2026/007 Tier 2 – medium impact Date of issue: 10 February 2026 Sulfadiazine silver (Flamazine®) 1% cream (250g) was discontinued in late December 2025, stock has been exhausted. Sulfadiazine silver (Flamazine®) 1% cream (50g) was discontinued [...]

The post Medicine Supply Notification: Sulfadiazine silver (Flamazine®) 1% cream appeared first on Community Pharmacy England.